Literature DB >> 7888227

Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1.

E G Shpaer1, E L Delwart, C L Kuiken, J Goudsmit, M H Bachmann, J I Mullins.   

Abstract

The third variable region (V3) of the surface glycoprotein (gp120) of envelope sequence subtype B, type 1 human immunodeficiency virus (HIV-1B), is highly variable among T cell line-adapted viruses and syncytium-inducing HIV-1-B isolates. Here we analyze the V3 region sequences from 93 individuals close to the time of seroconversion and show that the cysteine-bridged V3 loop, which also encompasses a major neutralizing determinant, is highly conserved, whereas sequences immediately surrounding the loop are similarly divergent in all HIV-1-B strains. Viruses with this conserved V3 loop have been reported to be more resistant to antibody-mediated neutralization than T cell-adapted viruses with divergent V3 sequences. We hypothesize, therefore, that on transmission from a donor to a recipient, virions inherently more resistant to neutralization by donor antibodies have a greater chance of initiating infection than those more sensitive to neutralization. This might explain the conservation of V3 early in infection and has implications for the design of HIV vaccines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888227     DOI: 10.1089/aid.1994.10.1679

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.

Authors:  Joshua T Herbeck; David C Nickle; Gerald H Learn; Geoffrey S Gottlieb; Marcel E Curlin; Laura Heath; James I Mullins
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.

Authors:  Qing Wei; Patricia N Fultz
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.

Authors:  H Ruppach; P Nara; I Raudonat; Z Elanjikal; H Rübsamen-Waigmann; U Dietrich
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Virus population homogenization following acute human immunodeficiency virus type 1 infection.

Authors:  Gerald H Learn; David Muthui; Scott J Brodie; Tuofu Zhu; Kurt Diem; James I Mullins; Lawrence Corey
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure.

Authors:  T Shiino; K Kato; N Kodaka; T Miyakuni; Y Takebe; H Sato
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family.

Authors:  H Sato; T Shiino; N Kodaka; K Taniguchi; Y Tomita; K Kato; T Miyakuni; Y Takebe
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission.

Authors:  Corey A Williams-Wietzikoski; Mary S Campbell; Rachel Payant; Airin Lam; Hong Zhao; Hannah Huang; Anna Wald; Wendy Stevens; Glenda Gray; Carey Farquhar; Helen Rees; Connie Celum; James I Mullins; Jairam R Lingappa; Lisa M Frenkel
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 populations in blood and semen.

Authors:  E L Delwart; J I Mullins; P Gupta; G H Learn; M Holodniy; D Katzenstein; B D Walker; M K Singh
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage.

Authors:  A Trkola; T Ketas; V N Kewalramani; F Endorf; J M Binley; H Katinger; J Robinson; D R Littman; J P Moore
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.